Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-49,236
Closed -$510K 130
2023
Q4
$510K Sell
49,236
-385,241
-89% -$3.64M 0.02% 130
2023
Q3
$4.89M Buy
434,477
+11,642
+3% +$147K 0.16% 125
2023
Q2
$4.86M Buy
422,835
+3,454
+0.8% +$43.1K 0.15% 124
2023
Q1
$5.83M Buy
419,381
+71,752
+21% +$1.03M 0.18% 124
2022
Q4
$4.57M Buy
347,629
+251,038
+260% +$3.35M 0.14% 130
2022
Q3
$1.36M Buy
+96,591
New +$1.57M 0.05% 132

Other funds holding EHAB

Aristotle Capital Boston's EHAB Position: Q1 2024 in Review

Aristotle Capital Boston sold out of Enhabit (EHAB) in Q1 2024, closing a stake of 49,236 shares — an estimated $510K sold.

Aristotle Capital Boston first reported a position in EHAB in Q3 2022 and held it in 6 quarters. The position peaked at $5.83M in Q1 2023. 182 funds tracked by Wall St. Rank hold EHAB as of Q1 2024.

  • Aristotle Capital Boston reported no remaining Enhabit position as of Q1 2024 after selling out during the quarter.
  • Aristotle Capital Boston sold 49,236 Enhabit shares in Q1 2024, an estimated $510K.
  • Aristotle Capital Boston first reported a position in Enhabit in Q3 2022 and held it in 6 quarters.
  • Aristotle Capital Boston's Enhabit position peaked at $5.83M in Q1 2023.
  • 182 funds tracked by Wall St. Rank held Enhabit as of Q1 2024.

Based on Aristotle Capital Boston's 13F filing for Q1 2024, filed 15 May 2024.